Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.

about

PET imaging in anal canal cancer: a systematic review and meta-analysis.

P2860

Q50260482-9E8944B7-9DFC-4C4A-9101-811C626EC7F2

P2860

Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.

Item

http://www.wikidata.org/entity/Q40780999

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Anal cancer FDG-PET standard u ...... eatment response and survival.

@en

type

Item

label

Anal cancer FDG-PET standard u ...... eatment response and survival.

@en

prefLabel

Anal cancer FDG-PET standard u ...... eatment response and survival.

@en

P1476

Anal cancer FDG-PET standard u ...... eatment response and survival.

@en

P2093

Carola Perotti

http://www.w3.org/2001/XMLSchema#string

Gianmauro Sacchetti

http://www.w3.org/2001/XMLSchema#string

Letizia Deantonio

http://www.w3.org/2001/XMLSchema#string

Lucia Turri

http://www.w3.org/2001/XMLSchema#string

Marco Brambilla

http://www.w3.org/2001/XMLSchema#string

Marco Krengli

http://www.w3.org/2001/XMLSchema#string

Maria Elisa Milia

http://www.w3.org/2001/XMLSchema#string

Tiziana Cena

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.

Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

Magnetic resonance imaging of anal cancer.

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.

P2888

s11547-015-0562-9

P304

54-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11547-015-0562-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26126968

http://www.w3.org/2001/XMLSchema#string

Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.

about

P2860

P2860

Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698